SJOGRENS SYNDROME
Clinical trials for SJOGRENS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGRENS SYNDROME trials appear
Sign up with your email to follow new studies for SJOGRENS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
8-Year trial tests Long-Term control of autoimmune dryness disease
Disease control OngoingThis study follows patients with Sjögren's syndrome for up to 8 years to check the long-term safety of the medication ianalumab. It includes 612 participants who previously completed one-year trials of the same drug. The research aims to see if continued treatment helps control d…
Matched conditions: SJOGRENS SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial tests potential Game-Changer for debilitating autoimmune disease
Disease control OngoingThis large, late-stage study is testing whether an investigational drug called nipocalimab can safely reduce disease activity and ease symptoms in adults with moderate to severe Sjogren's disease. It will compare the drug against a placebo in 655 participants over 48 weeks, measu…
Matched conditions: SJOGRENS SYNDROME
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC